|
30
|
134
|
7fxiA |
Crystal structure of human fabp4 in complex with rac-(1r,3s)-2,2-dimethyl-3-[(2-phenylphenyl)carbamoyl]cyclopropane-1-carboxylic acid |
|
35
|
134
|
7fw9A |
Crystal structure of human fabp4 in complex with 2-[(3-ethoxycarbonyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)carbamoyl]cyclopentene-1-carboxylic acid |
|
30
|
135
|
7fzaA |
Crystal structure of apo human fabp4, cubic form |
|
34
|
129
|
7g1xA |
Crystal structure of apo human fabp1 - monoclinic form i |
|
29
|
134
|
7fxuA |
Crystal structure of human fabp4 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dimethylthiophen-2-yl]carbamoyl]cyclopentene-1-carboxylic acid |
|
32
|
133
|
7fy3A |
Crystal structure of human fabp4 in complex with sulfate |
|
32
|
133
|
7g1sA |
Crystal structure of human fabp4 in complex with 3-(3,4-dichlorophenyl)-3,7a-dihydro-1h-imidazo[1,5-c][1,3]thiazole-5,7-dione |
|
31
|
133
|
7fzzA |
Crystal structure of human fabp4 in complex with 3-[(2,4-dichloro-5-methylphenyl)sulfonylamino]thiophene-2-carboxamide |
|
31
|
130
|
7fy4A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-benzyl-6-tert-butyl-3-methyl-4-phenyl-5-(1h-tetrazol-5-yl)pyridine |
|
31
|
134
|
7fwdA |
Crystal structure of human fabp4 in complex with 3-[1-(4-carbamoylphenyl)-5-(4-fluorophenyl)pyrrol-2-yl]propanoic acid |
|
29
|
134
|
7g1fA |
Crystal structure of human fabp4 in complex with 1-(4-methylphenyl)sulfonyl-3-(8-tricyclo[5.2.1.02,6]decanyl)urea |
|
31
|
134
|
7fxnA |
Crystal structure of human fabp4 in complex with 2-[(2s)-oxolan-2-yl]-4-phenyl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridine |
|
31
|
133
|
7fwgA |
Crystal structure of human fabp4 in complex with 1-[(4-chloro-3-phenoxyphenyl)methyl]-4-hydroxypyridin-2-one |
|
32
|
133
|
7g20A |
Crystal structure of human fabp4 in complex with 1-[(4-methoxyphenyl)methyl]-5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione |
|
30
|
134
|
7g21A |
Crystal structure of human fabp4 in complex with 4-hydroxy-2-[(e)-2-(2-phenylcyclohexyl)ethenyl]-2,3-dihydropyran-6-one |
|
33
|
133
|
7fy6A |
Crystal structure of human fabp4 in complex with 6-phenyl-11h-pyrimido[4,5-c][2]benzazepin-3-amine |
|
34
|
133
|
7fyxA |
Crystal structure of human fabp4 in complex with 2-[(3-phenylthiophen-2-yl)carbamoyl]cyclopentene-1-carboxylic acid |
|
31
|
135
|
7fx4A |
Crystal structure of human fabp4 in complex with rac-(1r,2s)-2-[(3,4-dichlorophenoxy)methyl]cyclohexane-1-carboxylic acid |
|
31
|
134
|
7fyrA |
Crystal structure of human fabp4 in complex with 5-(3,4-dichlorophenyl)-5-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione |
|
31
|
133
|
7fwpA |
Crystal structure of human fabp4 in complex with 3-hydroxy-4-[3-(3-methoxyphenyl)propyl]-2-(2-phenylethyl)-2h-furan-5-one |
|
32
|
134
|
7g08A |
Crystal structure of human fabp4 in complex with 2-(3-chloro-2-methylanilino)benzoic acid |
|
34
|
135
|
7g0fA |
Crystal structure of human fabp4 in complex with 6-[(3-methoxycarbonyl-4-thiophen-2-ylthiophen-2-yl)carbamoyl]cyclohex-3-ene-1-carboxylic acid |
|
29
|
135
|
7g0iA |
Crystal structure of human fabp4 in complex with 5-phenoxy-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
30
|
133
|
7fz2A |
Crystal structure of human fabp4 in complex with [3-oxo-5-[4-(trifluoromethyl)phenyl]cyclohexen-1-yl] acetate |
|
28
|
130
|
7g0oA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dimethylthiophen-2-yl]carbamoyl]cyclohexene-1-carboxylic acid |
|
32
|
135
|
7g06A |
Crystal structure of human fabp4 in complex with 5-(chloromethyl)-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
|
33
|
134
|
7fvuA |
Crystal structure of human fabp4 in complex with 2-[2-(benzothiophen-3-yl)-2,3-dihydrobenzothiophene-3-carbonyl]benzoic acid |
|
34
|
133
|
7g1iA |
Crystal structure of human fabp4 in complex with 5-(4-chlorophenyl)-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
31
|
133
|
7fz9A |
Crystal structure of human fabp4 in complex with n-methyl-6-(3-methylthiophen-2-yl)-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
30
|
134
|
7fzjA |
Crystal structure of human fabp4 in complex with 3-cyclohexyl-2-ethylsulfanyl-6-hydroxypyrimidin-4-one |
|
31
|
134
|
7fxhA |
Crystal structure of human fabp4 in complex with 2-[(2r)-oxolan-2-yl]-4-phenyl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridine |
|
33
|
133
|
7fwbA |
Crystal structure of human fabp4 in complex with 5-[2-(2,4-dichlorophenoxy)phenyl]-1h-tetrazole |
|
26
|
130
|
7g15A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with rac-(1r,2s)-2-[(3,4-dichlorophenoxy)methyl]cyclohexane-1-carboxylic acid |
|
31
|
133
|
7g0yA |
Crystal structure of human fabp4 in complex with 2-(2-methoxyanilino)benzoic acid |
|
28
|
127
|
7g0wA |
Crystal structure of apo human fabp1i monoclinic form ii, twinned with beta=90deg |
|
30
|
135
|
7fwjA |
Crystal structure of human fabp4 in complex with 5-cyclohexyl-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
32
|
134
|
7g02A |
Crystal structure of human fabp4 in complex with 7-methoxy-1-(3-methoxyphenyl)naphthalene-2-carboxylic acid |
|
31
|
134
|
7g0mA |
Crystal structure of human fabp4 in complex with 2-tert-butylsulfanyl-6-phenyl-1h-1,3,5-triazine-4-thione |
|
32
|
133
|
7g1zA |
Crystal structure of human fabp4 in complex with 5-[(4-chloro-3-phenoxyphenyl)methyl]-1h-tetrazole |
|
25
|
129
|
7fx3A |
Crystal structure of apo human fabp4, tetragonal form |
|
30
|
134
|
7g05A |
Crystal structure of human fabp4 in complex with 2,6-dichloro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenol |
|
29
|
130
|
7fx7A |
Crystal structure of human fabp4 with binding site mutated to fabp5 in complex with 5-methylsulfanyl-2-[(4-phenylmethoxy-1h-indazol-3-yl)methylsulfanyl]pyrimidin-4-ol |
|
31
|
133
|
7g0gA |
Crystal structure of human fabp4 in complex with 5-(3-bromo-4-methylphenyl)-3,3-dimethyl-5-oxopentanoic acid |
|
31
|
134
|
7fygA |
Crystal structure of human fabp4 in complex with 6-benzyl-2h-1,2,4-triazine-3,5-dithione |
|
31
|
134
|
7fx0A |
Crystal structure of human fabp4 in complex with 5-[(2-chloroanilino)methyl]-4-ethyl-1,2,4-triazole-3-thiol |
|
28
|
134
|
7g0zA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 5-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-4-carboxylic acid |
|
32
|
134
|
7fwnA |
Crystal structure of human fabp4 in complex with 3-(5-methyl-2,3-diphenylindol-1-yl)propanoic acid |
|
32
|
133
|
7g16A |
Crystal structure of human fabp4 in complex with 6-bromo-3-hexyl-2-oxo-3,4-dihydro-1h-quinoline-4-carboxylic acid |
|
30
|
134
|
7fyvA |
Crystal structure of human fabp4 in complex with 5-(4-chlorophenyl)-9-methyl-3-oxa-4-azatricyclo[5.2.1.02,6]dec-4-ene-8-carboxylic acid |
|
32
|
133
|
7g1bA |
Crystal structure of human fabp4 in complex with 2-[1-[(3-chlorophenyl)methyl]indol-2-yl]cyclopropane-1-carboxylic acid |
